Ornim Inc. develops a non-invasive, multi-modal monitoring platform for measuring vital physiologic parameters. Ornim’s FDA cleared devices enable continuous and safe monitoring of brain tissue oxygen saturation. Ornim’s breakthrough technology enables localized and quantitative measurements of physiological parameters within specific tissue regions. Ornim’s first application, Targeted Oximetry^TM,
enables monitoring of oxygen saturation in deep
tissues, particularly in the brain.